Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DiaMedica Therapeutics Q2 EPS $(0.17) Beats $(0.21) Estimate

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 19.05 percent. This is unchanged from the same period last year.
byBenzinga Newsdesk
August 11, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) by 19.05 percent. This is unchanged from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0